NIH-funded research R01 grant

A digital program to help people living with HIV quit smoking

Official title: Hybrid Trial of a Tailored Smoking Cessation Digital Therapeutic for Persons Living with HIV

Funded at Wake Forest University Health Sciences · NIH-11031384 · Data updated 2026-11-12

This study is testing a helpful online tool to support people living with HIV who want to quit smoking, using a friendly approach that understands their unique challenges.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWake Forest University Health Sciences
NIH-funded
Lab location1 site (Winston-Salem, United States)
Project startFebruary 9, 2024
Project endJanuary 31, 2029
Funding year2025
Award (this year)$619,707
NIH project number5R01CA285331-03
Project IDNIH-11031384 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals living with HIV who currently smoke and are seeking assistance to quit.

Less likely to help

Patients who do not smoke or those who are not living with HIV may not receive any benefit from this research.

What this research studies

This research focuses on developing and testing a digital therapeutic specifically designed to assist individuals living with HIV in quitting smoking. Given the high rates of tobacco use in this population, the study aims to create a tailored intervention that incorporates Acceptance and Commitment Therapy, which has shown promise in smoking cessation. Participants will engage with this digital tool, which is designed to be accessible and user-friendly, while also addressing the unique challenges faced by people living with HIV. The research will evaluate both the effectiveness of this intervention and the factors that influence its implementation in real-world settings.

Why it matters

Potential benefit: If successful, this research could significantly improve smoking cessation rates among people living with HIV, leading to better overall health outcomes.

How similar studies have gone: While digital therapeutics for smoking cessation have been effective in the general population, this specific approach tailored for people living with HIV is novel and has not been extensively tested before.

Where this research is happening

  • Wake Forest University Health Sciences
    Winston-Salem, United States
    Active

Researchers

  • Principal investigator: Vilardaga, Roger — Wake Forest University Health Sciences
  • Study coordinator: Vilardaga, Roger

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.